Print
Covid 19
Sun Pharma
JOINS PATIENTS IN
THANKING
all doctors for their
SELFLESS SERVICE
VIEW VIDEO
Covid 19
Sun Pharma
INITIATES PHASE II CLINICAL TRIAL ON AQCH,
a phytopharmaceutical drug,
AS POTENTIAL TREATMENT FOR COVID-19 PATIENTS
KNOW MORE
Corporate Movie
EVOLUTION OF SUN
From humble beginnings
in 1983
to a brand trusted worldwide
WATCH OUR VIDEO
Sun Pharmaceutical Ltd. - world's 4th largest company
WORLD's 4th LARGEST
Speciality Generic
PHARMACEUTICAL COMPANY

READ ABOUT SUN PHARMA
High quality medicines
We Develop High-Quality,
AFFORDABLE MEDICINES TRUSTED BY
Healthcare Professionals & Patients
IN 100 COUNTRIES ACROSS SIX CONTINENTS
READ ABOUT OUR PRODUCTS
Sunpharma products
Our Product offerings
HAVE THE HALLMARK OF
Technology-Based
DIFFERENTIATION
READ ABOUT OUR R&D
Sunpharma careers
Our multi-cultural team
OF MORE THAN
30,000 EMPLOYEES
is our most
VALUABLE ASSET
READ ABOUT OUR CULTURE
Sunpharma quality
Our Passion for Quality
GOES BEYOND BUSINESS
Putting Patients First
IS OUR MOTTO
READ ABOUT OUR QUALITY

Financial Updates

06 JUL
FY20 Q4 Financial Result - Transcript
27 MAY
FY20 Q4 Financial Press Release
27 MAY
FY20 Q4 Financial Results
Read More

Press Releases

29 JUN
Sun Pharma announces Japan MHLW approval of ILUMYA for the treatment of Plaque Psoriasis
24 JUN
Sun Pharma Announces Pre-Clinical Data on GL0034
15 JUN
Sun Pharma and Hikma enter into exclusive licensing agreement for ILUMYA™ for Middle East & North Africa regions
Read More